Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Clinical Oncology Society of Australia (COSA) Conference, 2-4 Nov 2022

Clinical Oncology Society of Australia (COSA) Conference, 2-4 Nov 2022

  • November 3, 2022

This week NECA attended the Clinical Oncology Society of Australia’s (COSA) Annual Scientific meeting in Brisbane, directly following the NET Patient Forum the evening prior.

This is always a great opportunity to raise awareness of NETs with healthcare professionals Australia wide and meet again with fellow specialists in the area of NETs.

NECA CEO, Meredith Cummins, submitted an abstract for the “Living with NETs Program”. This was reviewed and chosen to be an oral presentation at the conference. The presentation gave a brief overview of the incidence and prevalence of NETs in Australia and the background for the development of the education program.

In the planning for the program it was noted that the current Cancer Education Programs (CEP) did not meet the needs of NET patients. The working group which consisted of NECA nurses, Cancer Council Victoria CEP education and training coordinators and NET patient consumers. The NET community were invited to be involved in topics which could be included.

From this feedback pilot 1 was developed and implemented. The program would run for 1.5 hours each week for 4 consecutive weeks. Further evaluation of the program from the attendees of pilot 1 was received and recommendations for improvement were made to pilot 2. The main change for this pilot was to make each weekly session 2 hours instead of 1.5 hours. Sessions attendees could not attend were recorded and sent to the attendee. The feedback from both pilots has been so positive and the information presented has so beneficial to the attendees and enhanced their basic knowledge of NETs, their ability to self-advocate, navigate the system and understand treatment options – what could be used when and why.

The official launch of the “Living with NETs program was 24 October 2022 and we will be looking to conduct 2 programs in 2023. To our delight this presentation won “Best of the Oral Presentations – Education” at the COSA Conference.

Share this post

Recent posts

Announcing our First Patient Ambassador – Cassie Miller

June 17, 2025

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

June 16, 2025

2025 Impact Report

June 16, 2025

Be the Voice for NET Patients in WA – Join Our CAG Team

June 10, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousCOSA Neuroendocrine Neoplasms (NENs) guidelines open for public consultation
NextNET Cancer Day 2022Next

Related Posts

Announcing our First Patient Ambassador – Cassie Miller

NeuroEndocrine Cancer Australia is proud to welcome Cassie Miller from Queensland as our very first official Patient Ambassador. Cassie was 36 when she was diagnosed

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NeuroEndocrine Cancer Australia (NECA) was proud to attend the 5th Neuroendocrine Tumour (NET) Preceptorship held 13 & 14th June at Peter MacCallum Cancer Centre in

2025 Impact Report

This year, NeuroEndocrine Cancer Australia continued to expand our reach and impact thanks to the incredible support of our community. Click below to read the

Be the Voice for NET Patients in WA – Join Our CAG Team

Call out for a consumer advisory representative from Western Australia (voluntary position) Are you from Western Australia? Have you experienced a diagnosis of a Neuroendocrine

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin